Makes catheters for diagnosing cardiovascular disease.
Aug 2026Revenue $325M/yrExpenses $362M/yr
No trend
Figures by year
When will Angiodynamics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Aug 2026, revenue was $325M and expenses $362M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| May 2026 | $320M | $360M | −$39.9M |
| May 2025 | $292M | $332M | −$40.0M |
| May 2024 | $304M | $496M | −$192M |
| May 2023 | $339M | $390M | −$51.2M |
| May 2022 | $316M | $345M | −$28.5M |
| May 2021 | $291M | $326M | −$35.3M |
| May 2020 | $264M | $431M | −$167M |
| May 2019 | $271M | $280M | −$9.40M |
| May 2018 | $262M | $276M | −$14.2M |
| May 2017 | $270M | $281M | −$11.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.